Healthcare Triangle Secures $478,000 Through Warrant Exercise Agreements

Healthcare Triangle, Inc. (Nasdaq: HCTI) has entered into warrant exercise agreements with existing accredited and institutional investors to exercise outstanding warrants for an aggregate of 239,051 shares of common stock. The transaction generates approximately $478,000 in gross cash proceeds for the company, providing immediate capital infusion to support ongoing operations and strategic initiatives in the competitive healthcare technology sector.

In consideration for the immediate exercise of existing warrants, the participating investors will receive new unregistered warrants to purchase up to 239,051 shares of common stock with an exercise price of $3.00 per share. These new warrants are immediately exercisable upon issuance and will remain valid for five years, creating potential future capital opportunities for Healthcare Triangle while offering investors continued participation in the company's growth trajectory. The company agreed to reduce the exercise price of the existing warrants from $20.92 to $2.00 per share to facilitate the transaction, reflecting current market conditions and strategic financial management.

The warrant inducement transaction, expected to close on October 8, 2025, represents a strategic move by Healthcare Triangle to strengthen its balance sheet while maintaining investor relationships. WallachBeth Capital is serving as financial advisor for the transaction, bringing expertise in structured financial arrangements and capital market transactions. The gross proceeds of approximately $478,000 exclude potential future proceeds from the exercise of new warrants and account for financial advisor fees and other transaction expenses payable by the company.

This capital raise occurs as Healthcare Triangle continues to expand its digital transformation solutions for healthcare and life sciences organizations. The company's focus on cloud services, data platform management, and healthcare interoperability positions it within growing market segments where technology adoption is accelerating. The immediate funding provides operational flexibility and resources to pursue growth opportunities in an industry increasingly dependent on sophisticated data management and security solutions.

Healthcare Triangle's achievement of HITRUST Certification for its Cloud and Data Platform demonstrates the company's commitment to meeting rigorous data protection and information security standards. This certification, covering products marketed as CloudEz™ and DataEz™, reinforces the company's competitive positioning in serving highly regulated healthcare and life sciences organizations that require robust security compliance. The additional capital from this warrant exercise transaction may support further development of these certified platforms and expansion of the company's service offerings to healthcare providers, payers, and pharmaceutical companies.